Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Biogen Inc (AKA: Biogen Research Corporation)
Profile last edited on: 8/6/2024      CAGE: 3BQ77      UEI: YDUSCWHBCEN9

Business Identifier: Biopharmaceutical genetic engineering
Year Founded
1978
First Award
1986
Latest Award
1988
Program Status
Inactive (Acquired)
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

14 Cambridge Center
Cambridge, MA 02142
   (617) 679-2000
   info@biogen.com
   www.biogen.com
Location: Multiple
Congr. District: 07
County: Middlesex

Public Profile

Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide.

Extent of SBIR involvement

User Avatar
Phase I Awards
4
Phase II Awards
1
Conversion Rate
25.00%
Phase I Dollars
$200,000
Phase II Dollars
$300,000
Total Awarded
$500,000

Synopsis: Awardee Business Condition

Employee Range
500+
Revenue Range
Over 50M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : BGEN
IP Holdings
500+

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
1988 2 NIH $350,000
Project Title: Mullerian Inhabiting substance
1987 1 NIH $50,000
Project Title: Production of Recombinant Proteins in Milk
1987 1 NIH $50,000
Project Title: Soluble MHC Molecules to induce allograft tolerance
1986 1 NIH $50,000
Project Title: Soluble Recombinant T4 Protein--Novel Therapy for AIDS

Key People / Management

Company News

Jun 03 2019
Better Buy: Biogen vs. Amgen